RDSH Due Diligence

New Post Public Reply Private Reply Replies (0) Message Board
debonaire1984
RDSH Due Diligence

Tautachrome Inc. is a wholly owned subsidiary of Roadships Holdings, Inc. RDSH
http://www.tautachrome.com/

KlickZie is a system aimed at turning the camera in any iPhone, Android or other smartphone into a camera that automatically creates what we call trustable pictures and videos.
The future of KlickZie is led by Dr. Jon Leonard and a team of scientists with extensive experience working on the edges of technology.

Here are the links I've compiled so far showing the background some of our management here. It includes names like Raytheon, NASA, American Institute of Aeronautics and Astronautics, University of Hawaii's Institute for Astronomy, and Texas A&M University.
It also shows patents that our CEO/Founder, Jon Leonard and Co-Founder/Chief Engineer, Matt Staker have been granted.

Jon N. Leonard, PhD

A Mars Colonization Approach that was submitted to The American Institute of Aeronautics and Astronautics (AIAA)
http://arc.aiaa.org/doi/abs/10.2514/6.2007-6135

List of all Patents associated with Dr. Jon N. Leonard
http://patents.justia.com/inventor/jon-n-leonard

Raytheon Newsletter showing that Dr Leonard had received patent through Raytheyon:
http://www.raytheon.com/news/technology_today...2010_2.pdf
(pg 55:
JON N. LEONARD
JAMES SMALL
4490433 Mass spectrometer for entrained particles, and method for measuring masses of the particles)

5th International Symposium on Mixed and Augmented Reality (ISMAR 2006)
http://ronaldazuma.com/papers/ISMAR06_final.pdf

Shows him as attendee at the 2011 systems engineering research center annual research review
http://www.sercuarc.org/wp-content/uploads/20...e-List.pdf

Joel Sercel, PhD

NASA SBIR 2015 Proposal
Demonstration of "Optical Mining" For Excavation of Asteroids and Production of Mission Consumables
http://sbir.nasa.gov/SBIR/abstracts/15/sbir/p...-9278.html

Seminar given by Dr. Sercel at University of Hawaii's Institute for Astronomy
https://www.ifa.hawaii.edu/colloquia/abstract...ercel.html

Links showing that Dr. Sercel's proposal was selected by NASA for study under the NASA Innovative Advanced Concepts (NIAC), a program that aims to turn science fiction into science fact through the development of pioneering technologies.
http://www.parabolicarc.com/2015/05/08/niac/
http://www.nasa.gov/feature/niac-2015-phase-i...selections
http://www.nasa.gov/feature/apis-asteroid-pro...e-falcon-9

Seminar at Texas A&M University
https://engineering.tamu.edu/media/2154178/SE...cement.pdf

Link showing Dr. Sercel quoted in article about NASA's Asteroid Initiative and talking about ICS Associates Honey Bee project
http://spacenews.com/37559commercial-firms-pu...nitiative/

Article about his Asteroid Mining business model
http://www.space.com/30582-asteroid-mining-wa...lsion.html


Matthew Staker

List of all Patents associated with Matthew Staker
http://patents.justia.com/inventor/matthew-staker

Matthew Staker was founder/chief technologist in VisualSoftware, which was acquired by Micrografx for approximately $17 million (inflation adjusted)
http://www.thefreelibrary.com/MICROGRAFX+COMP...a018157203

Matthew Staker - New Image Industries, Inc
http://www.bloomberg.com/research/stocks/priv...pId=291000
SC 14D1/A for DENTSPLY acquisition of New Image Industries, Inc
http://www.secinfo.com/dsvrv.8Je.htm#1stPage
Article about New Image Industries, Inc's "The New Image 610 Landscape Design System", mentioning Matt Staker
http://landscapeonline.com/research/article/9460
"The 610 Landscape Design System dates from 1984, with the research and marketing of the successful NIII ‘hair salon’ system. At the time John Halloran, a successful physicist began researching the system. Later he was to team up with Bob Garavitch, a businessman who has worked for Revlon and other cosmetic firms, to finalize studies on the hair salon system to bring it to market. With the help of Matt Staker, an imaginative programmer, the imaging system became a reality."



When the world changed on 9-11, Jon joined Raytheon as the Director of Counter Terrorism Technology ... Jon left Raytheon to develop Click Evidence, Inc. and the KlickZie technology
The KlickZie concept consists of downloadable software able to securitize the imaging process in the smartphone, together with an advanced cloud system to authenticate KlickZie pictures and videos and to make possible imagery based communication among people who happen upon KlickZie pictures and videos.

Dr. Jon Leonard: CEO/Co-Founder:
" our strategy is to put KlickZie into the hands of consumers as a free download whose imagery is as beautiful and engaging as Instagram is at its best...You run across a picture on the web. You Like it , It's a KlickZie Picture (The KlickZie symbol is shown) , Talk to the Author ! ...We want KlickZie to be as widely used as Facebook and as deeply embedded in the social / business fabric as email...We will license our KlickZie engine to enterprises where trustable imagery is mission critical KlickZie user base will quickly grow to the capacity of the smartphone user space... 2 billion Worldwide users of smartphones , 500000 Images uploaded every minute to Instagram and Facebook...If it's not KlickZied - you can't trust it … Be able to trust images once more...that accomplishment will produce the basis for KlickZie revenues through ad placement (like Google) and “in-app” selling of premium user services (like LinkedIn) "
http://www.klickzie.com/

In RDSH there is no dilution , nor reverse split nor fake news. RDSH Is a non - dilutive co. that our New Ceo. Dr. Leonard and the Klickzie Crew , took over On MAY 2015 , changing the co. from a shipping business to a whole new technology direction .
Dr. Leonard and his crew have spent the vast majority of 2015 auditing all RDSH financial records and making themselves more attractive for investors and VCs.
After putting out : 4 10-k , 11 8-k , 8 10-q , 1 sc-13d and 7 news about done progresses in the company - RDSH became current as of September 2015
http://www.otcmarkets.com/stock/RDSH/filings


SRI’s Center for Vision Technologies under Mike Piacentino’s leadership worked with Jon in the development of the MANTIS soldier imaging system for the US Army, under a $40 million DARPA program that Jon defined and managed while at Raytheon.

Some proof that they've worked together before:

Dr. Leonard talking about MANTIS in 2006.
http://www.afcea.org/content/?q=us-recoups-nighttime-primacy

Mike Piacentino on MANTIS
http://archive.defensenews.com/print/article/...moke-night

Mike Piacentino profile on SRI
https://www.sri.com/about/people/michael-piacentino

Share Structure:
A/S: 3,000,000,000
O/S: 2,989,933,770
Float: 530,213,651
Restricted shares own by Insiders/Management: 2,459,720,119 or 82.2% of O/S
Share Structure has remained same since 2013. NO issuance of new shares to acquire Click Evidence.

601,973,223 TOTAL volume since RDSH announced intent to acquire Click Evidence, now known as Tautachrome (4/27/2015)
427,238,537 TOTAL volume from announcement to acquisition finalized (5/21/2015)
ONLY 174,734,686 TOTAL volume in the last 5+ months since acquisition finalized.

So, since the acquisition was finalized, only 1/3 of the total float has changed hands. AT THE VERY MINUMUM, shareholders of at least 2/3 of the float refused to sell from the Acquisition date to the run up of 441% to the high of .039 and beyond to the present day.

Even since the day of the high of .039, only 9,689,150 (1.8% of float) sold. That's FAR from a massive selloff or people running for the exit.
Yes, the fact that it came back down to settle in the 2s does mean there is a lack of bid support to maintain the highs. HOWEVER it also means that VERY few are willing to let go of their shares .

Turth be told, a lack of bid support is bound to happen when there is a sudden run up of over 400% on only 28,973,064 volume (5.4% of float) and no news. Less people will want to buy at a higher price when they are hoping for a pullback. It needed to settle down.

If you ignore all those that flipped for profit throughout the entire run up since 9/17/2015, and factor in all those that traded after the high, you can only expect MAYBE 19,283,914 shares to be sold by those that bought since this run began.
If you do factor in shares that had exchanged hands multiple times by traders flipping for profit, it is likely that there are FAR fewer shares left that could be likely to be sold by those that bought in the range of .007-.023(the current price). And we already know that there are still new investors here that bought above a penny that are holding millions for a far higher price. That is yet another thing you would have to factor in to the equation.

At the end of the day, considering that, as of yet, AT LEAST 93% have not taken any profits since the current run, it's safe to assume that it's actually FAR more than 2/3 of the float that is locked up tight.


All information of volume traded was found via the below link and calculated by myself.
http://www.nasdaq.com/symbol/rdsh/interactive-chart

Roadships Holdings (RDSH) Stock Research Links

RDSH Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 6

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading

Top 5 Most Recently Viewed Articles

GeeLark's Mobile-Cloud Push Redefines Social Media Ops

Updated Category News Views 8

Riding the Mobile Wave: A New Era in Digital Marketing Folks, GeeLark's latest move is like a sledgehammer to an old wall. Smashed it with their recent rollout of a unified Browser and Cloud Phone platform. This isn't just upgrading the toolbox—it's overhauling the whole workshop. As someone who's seen enough tech promises fizzle, this one might actually stick....

Continue Reading
Seven & i Holdings Expands Convenience Store Footprint Across North America

Updated Category News Views 377

Seven & i Holdings Plans Major Expansion in North America Japan's Seven & i Holdings has unveiled its ambitious plan to establish 500 new convenience stores in the United States and Canada by 2027. This strategic move comes as the company seeks to solidify its presence in the North American market and compete against local and international convenience store chains....

Continue Reading
How Russia Has Embraced Bitcoin Amidst Economic Challenges

Updated Category News Views 212

Bitcoin's Enduring Presence in Russia Not long ago, Russian President Vladimir Putin took a bold stance by declaring that Bitcoin could not be banned, regardless of any attempts by governments around the globe. This declaration underscored a potential shift in the country's approach to cryptocurrency amidst the backdrop of escalating international sanctions. Putin's...

Continue Reading
Jumptuit Receives USPTO Allowance for Innovative AI Patent

Updated Category News Views 363

Jumptuit's Progress in Artificial Intelligence Technology Jumptuit, a prominent company in the field of AI research and development, has recently marked a significant milestone in its innovative journey. The U.S. Patent and Trademark Office (USPTO) has granted Jumptuit a Notice of Allowance, enhancing its protection for cutting-edge AI Search Technology. This development...

Continue Reading
Harbour BioMed Unveils Promising Results for HBM1020

Updated Category News Views 110

Harbour BioMed Shares Exciting Results for HBM1020 Harbour BioMed, a global biopharmaceutical company dedicated to creating groundbreaking antibody therapeutics, has reached significant milestones in its clinical research. The company recently shared incredible clinical data on HBM1020, a first-of-its-kind fully human anti-B7H7/HHLA2 monoclonal antibody. This information...

Continue Reading